Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer

Details for Australian Patent Application No. 2005320352 (hide)

International Classifications

Event Publications

31 August 2006 Application Open to Public Inspection

Published as AU-A-2005320352

31 August 2006 PCT application entered the National Phase

6 September 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 14 Aug 2007

4 October 2007 Section 223 Application Allowed

Compugen USA, Inc. The time in which to request examination has been extended to 13 Sep 2007. Address for service in Australia - Pipers Suite 1, Coronation Place 10 Benson Street Toowong QLD 4066 2006

30 April 2009 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the Name Compugen USA, Inc., Application No. 2005320352, under INID (43) correct the date to 14.12.06

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.